Site Members can sign up for company wide alerts
Lawsuit Overview
An investor in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) filed a lawsuit against directors of Ultragenyx Pharmaceutical Inc over alleged excessive pay of certain directors. The plaintiff alleges alleging that the board has breached its fiduciary duty and engaged in self-dealing, unjust enrichment and waste in approving a compensation plan that grossly overcompensates ...
You must register (for free) or login to view the entire case.